19 / 27
Page 64
Notes:
conferenceseries
.com
Volume 7, Issue 7 (Suppl)
J Gastrointest Dig Syst
ISSN: 2161-069X JGDS, an open access journal
Gastroenterologists 2017
December 14-15, 2017
December 14-15, 2017 Dubai, UAE
11
th
World
Gastroenterologists Summit
The investigation and management of rectal neuroendocrine tumors
Raj Srirajaskanthan
Kings College Hospital, UK
R
ectal neuroendocrine tumors (NETs) are increasingly identified at endoscopy the cause of which may be in part related
to bowel cancer screening programs. This lecture will aid clinicians in the diagnosis and management of rectal NETs plus
cutting edge advances in treatment. Whilst most rectal NETs are <1 cm there are specific endoscopic characteristics to help
diagnose these tumors and also determine optimal management. These include size, atypical appearance, grade and depth of
invasion. The primary resection modality influences complete resection rates and the need for secondary therapy. A thorough
pre-resection diagnostic work up is required for lesions that are at higher risk of invasion and metastasis. Device-assisted
endoscopic mucosal resection (EMR) and endoscopic sub-mucosal dissection (ESD) are used to resect localized rectal NETs
<2 cm. The treatment of advanced disease is multi-modal.
r.srirajaskanthan@nhs.netJ Gastrointest Dig Syst 2017, 7:7 (Suppl)
DOI: 10.4172/2161-069X-C1-062